nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CYP1A2—Carmustine—brain cancer	0.203	0.771	CbGbCtD
Atropine—CYP1A2—Etoposide—brain cancer	0.0603	0.229	CbGbCtD
Atropine—Unsteadiness—Procarbazine—brain cancer	0.0341	0.0491	CcSEcCtD
Atropine—Intoxication—Hydroxyurea—brain cancer	0.0197	0.0283	CcSEcCtD
Atropine—Poisoning—Hydroxyurea—brain cancer	0.0197	0.0283	CcSEcCtD
Atropine—Blindness—Lomustine—brain cancer	0.0195	0.028	CcSEcCtD
Atropine—Slurred speech—Procarbazine—brain cancer	0.0153	0.022	CcSEcCtD
Atropine—Dolasetron—CYP2C9—brain cancer	0.0147	0.697	CrCbGaD
Atropine—Hyperaemia—Carmustine—brain cancer	0.0142	0.0204	CcSEcCtD
Atropine—Balance disorder—Procarbazine—brain cancer	0.0125	0.018	CcSEcCtD
Atropine—Dysarthria—Lomustine—brain cancer	0.0114	0.0164	CcSEcCtD
Atropine—Disorientation—Lomustine—brain cancer	0.00874	0.0126	CcSEcCtD
Atropine—Blepharitis—Hydroxyurea—brain cancer	0.0086	0.0124	CcSEcCtD
Atropine—Petechiae—Procarbazine—brain cancer	0.00831	0.012	CcSEcCtD
Atropine—Lethargy—Lomustine—brain cancer	0.00798	0.0115	CcSEcCtD
Atropine—Osteoarthritis—Lomustine—brain cancer	0.00782	0.0113	CcSEcCtD
Atropine—Ataxia—Lomustine—brain cancer	0.00735	0.0106	CcSEcCtD
Atropine—Dysarthria—Procarbazine—brain cancer	0.00723	0.0104	CcSEcCtD
Atropine—Visual acuity reduced—Temozolomide—brain cancer	0.00695	0.01	CcSEcCtD
Atropine—Photophobia—Procarbazine—brain cancer	0.00642	0.00925	CcSEcCtD
Atropine—Cocaine—CYP2C9—brain cancer	0.0064	0.303	CrCbGaD
Atropine—Paranoia—Carmustine—brain cancer	0.00628	0.00904	CcSEcCtD
Atropine—Coma—Procarbazine—brain cancer	0.00625	0.009	CcSEcCtD
Atropine—Stupor—Carmustine—brain cancer	0.00573	0.00825	CcSEcCtD
Atropine—Disorientation—Procarbazine—brain cancer	0.00555	0.00799	CcSEcCtD
Atropine—Lethargy—Procarbazine—brain cancer	0.00507	0.0073	CcSEcCtD
Atropine—Skin exfoliation—Hydroxyurea—brain cancer	0.00505	0.00728	CcSEcCtD
Atropine—Petechiae—Temozolomide—brain cancer	0.00503	0.00724	CcSEcCtD
Atropine—Blood urea increased—Hydroxyurea—brain cancer	0.005	0.0072	CcSEcCtD
Atropine—Speech disorder—Carmustine—brain cancer	0.00497	0.00717	CcSEcCtD
Atropine—Rash maculo-papular—Hydroxyurea—brain cancer	0.00481	0.00693	CcSEcCtD
Atropine—Speech disorder—Temozolomide—brain cancer	0.00481	0.00692	CcSEcCtD
Atropine—Pulmonary oedema—Hydroxyurea—brain cancer	0.00471	0.00679	CcSEcCtD
Atropine—Cyanosis—Etoposide—brain cancer	0.00467	0.00673	CcSEcCtD
Atropine—Ataxia—Procarbazine—brain cancer	0.00467	0.00672	CcSEcCtD
Atropine—Leukocytosis—Carmustine—brain cancer	0.00455	0.00656	CcSEcCtD
Atropine—Laryngospasm—Etoposide—brain cancer	0.00443	0.00638	CcSEcCtD
Atropine—Disorientation—Hydroxyurea—brain cancer	0.00429	0.00619	CcSEcCtD
Atropine—Dysphagia—Procarbazine—brain cancer	0.00429	0.00618	CcSEcCtD
Atropine—Injection site reaction—Carmustine—brain cancer	0.00425	0.00613	CcSEcCtD
Atropine—Respiratory failure—Temozolomide—brain cancer	0.00421	0.00606	CcSEcCtD
Atropine—Angina pectoris—Procarbazine—brain cancer	0.00418	0.00602	CcSEcCtD
Atropine—Depressed level of consciousness—Carmustine—brain cancer	0.00413	0.00595	CcSEcCtD
Atropine—Skin exfoliation—Carmustine—brain cancer	0.00408	0.00588	CcSEcCtD
Atropine—Depressed level of consciousness—Temozolomide—brain cancer	0.00399	0.00575	CcSEcCtD
Atropine—Skin exfoliation—Temozolomide—brain cancer	0.00395	0.00569	CcSEcCtD
Atropine—Coma—Carmustine—brain cancer	0.00391	0.00563	CcSEcCtD
Atropine—Drowsiness—Procarbazine—brain cancer	0.00383	0.00551	CcSEcCtD
Atropine—Dry eye—Temozolomide—brain cancer	0.00382	0.0055	CcSEcCtD
Atropine—Pain—Carboplatin—brain cancer	0.00376	0.00541	CcSEcCtD
Atropine—Sweating—Procarbazine—brain cancer	0.00367	0.00528	CcSEcCtD
Atropine—Swelling—Carmustine—brain cancer	0.00352	0.00507	CcSEcCtD
Atropine—Body temperature increased—Carboplatin—brain cancer	0.00347	0.005	CcSEcCtD
Atropine—Eye pain—Carmustine—brain cancer	0.00344	0.00496	CcSEcCtD
Atropine—Hallucination—Procarbazine—brain cancer	0.00342	0.00492	CcSEcCtD
Atropine—Eye pain—Temozolomide—brain cancer	0.00332	0.00479	CcSEcCtD
Atropine—Amnesia—Carmustine—brain cancer	0.00331	0.00476	CcSEcCtD
Atropine—Nasal congestion—Temozolomide—brain cancer	0.00329	0.00475	CcSEcCtD
Atropine—Amnesia—Temozolomide—brain cancer	0.00319	0.0046	CcSEcCtD
Atropine—Flushing—Procarbazine—brain cancer	0.00319	0.00459	CcSEcCtD
Atropine—Skin exfoliation—Etoposide—brain cancer	0.00316	0.00455	CcSEcCtD
Atropine—Thirst—Temozolomide—brain cancer	0.00315	0.00454	CcSEcCtD
Atropine—Hyponatraemia—Carmustine—brain cancer	0.00312	0.00449	CcSEcCtD
Atropine—Dysuria—Hydroxyurea—brain cancer	0.0031	0.00447	CcSEcCtD
Atropine—Arrhythmia—Procarbazine—brain cancer	0.00307	0.00442	CcSEcCtD
Atropine—Body temperature increased—Lomustine—brain cancer	0.00304	0.00438	CcSEcCtD
Atropine—Rash maculo-papular—Etoposide—brain cancer	0.00301	0.00433	CcSEcCtD
Atropine—Drowsiness—Hydroxyurea—brain cancer	0.00296	0.00426	CcSEcCtD
Atropine—Tension—Procarbazine—brain cancer	0.00293	0.00423	CcSEcCtD
Atropine—Ataxia—Carmustine—brain cancer	0.00292	0.00421	CcSEcCtD
Atropine—Nervousness—Procarbazine—brain cancer	0.0029	0.00418	CcSEcCtD
Atropine—Hypokalaemia—Carmustine—brain cancer	0.00283	0.00407	CcSEcCtD
Atropine—Ataxia—Temozolomide—brain cancer	0.00282	0.00407	CcSEcCtD
Atropine—Dehydration—Temozolomide—brain cancer	0.00279	0.00402	CcSEcCtD
Atropine—Dry skin—Temozolomide—brain cancer	0.00275	0.00396	CcSEcCtD
Atropine—Hypokalaemia—Temozolomide—brain cancer	0.00273	0.00393	CcSEcCtD
Atropine—Swelling—Etoposide—brain cancer	0.00272	0.00392	CcSEcCtD
Atropine—Dysphagia—Carmustine—brain cancer	0.00268	0.00387	CcSEcCtD
Atropine—Syncope—Procarbazine—brain cancer	0.00268	0.00386	CcSEcCtD
Atropine—Hallucination—Hydroxyurea—brain cancer	0.00264	0.00381	CcSEcCtD
Atropine—Loss of consciousness—Procarbazine—brain cancer	0.00263	0.00378	CcSEcCtD
Atropine—Abdominal distension—Temozolomide—brain cancer	0.00261	0.00376	CcSEcCtD
Atropine—Dysphagia—Temozolomide—brain cancer	0.00259	0.00374	CcSEcCtD
Atropine—Convulsion—Procarbazine—brain cancer	0.00259	0.00373	CcSEcCtD
Atropine—Anxiety—Procarbazine—brain cancer	0.00254	0.00365	CcSEcCtD
Atropine—Dry mouth—Procarbazine—brain cancer	0.00249	0.00359	CcSEcCtD
Atropine—Confusional state—Procarbazine—brain cancer	0.00246	0.00354	CcSEcCtD
Atropine—Vomiting—Lomustine—brain cancer	0.00244	0.00352	CcSEcCtD
Atropine—Oedema—Procarbazine—brain cancer	0.00244	0.00351	CcSEcCtD
Atropine—Dysuria—Temozolomide—brain cancer	0.00243	0.00349	CcSEcCtD
Atropine—Hyperglycaemia—Carmustine—brain cancer	0.00242	0.00349	CcSEcCtD
Atropine—Shock—Procarbazine—brain cancer	0.0024	0.00346	CcSEcCtD
Atropine—Erectile dysfunction—Temozolomide—brain cancer	0.00239	0.00344	CcSEcCtD
Atropine—Depression—Carmustine—brain cancer	0.00239	0.00344	CcSEcCtD
Atropine—Tachycardia—Procarbazine—brain cancer	0.00238	0.00343	CcSEcCtD
Atropine—Hyperhidrosis—Procarbazine—brain cancer	0.00236	0.0034	CcSEcCtD
Atropine—Hyperglycaemia—Temozolomide—brain cancer	0.00234	0.00337	CcSEcCtD
Atropine—Erythema—Hydroxyurea—brain cancer	0.00231	0.00333	CcSEcCtD
Atropine—Depression—Temozolomide—brain cancer	0.00231	0.00332	CcSEcCtD
Atropine—Cardiac arrest—Etoposide—brain cancer	0.00228	0.00329	CcSEcCtD
Atropine—Nausea—Lomustine—brain cancer	0.00228	0.00329	CcSEcCtD
Atropine—Hypotension—Procarbazine—brain cancer	0.00228	0.00328	CcSEcCtD
Atropine—Insomnia—Procarbazine—brain cancer	0.00221	0.00318	CcSEcCtD
Atropine—Somnolence—Procarbazine—brain cancer	0.00217	0.00312	CcSEcCtD
Atropine—Hallucination—Carmustine—brain cancer	0.00214	0.00308	CcSEcCtD
Atropine—Fatigue—Procarbazine—brain cancer	0.0021	0.00303	CcSEcCtD
Atropine—Pain—Procarbazine—brain cancer	0.00209	0.00301	CcSEcCtD
Atropine—Constipation—Procarbazine—brain cancer	0.00209	0.00301	CcSEcCtD
Atropine—Dysphagia—Etoposide—brain cancer	0.00208	0.00299	CcSEcCtD
Atropine—Hallucination—Temozolomide—brain cancer	0.00207	0.00298	CcSEcCtD
Atropine—Feeling abnormal—Procarbazine—brain cancer	0.00201	0.0029	CcSEcCtD
Atropine—Convulsion—Hydroxyurea—brain cancer	0.002	0.00289	CcSEcCtD
Atropine—Gastrointestinal pain—Procarbazine—brain cancer	0.00199	0.00287	CcSEcCtD
Atropine—Flushing—Carmustine—brain cancer	0.00199	0.00287	CcSEcCtD
Atropine—Urticaria—Procarbazine—brain cancer	0.00194	0.00279	CcSEcCtD
Atropine—Abdominal pain—Procarbazine—brain cancer	0.00193	0.00278	CcSEcCtD
Atropine—Body temperature increased—Procarbazine—brain cancer	0.00193	0.00278	CcSEcCtD
Atropine—Flushing—Temozolomide—brain cancer	0.00193	0.00278	CcSEcCtD
Atropine—Arrhythmia—Carmustine—brain cancer	0.00192	0.00276	CcSEcCtD
Atropine—Oedema—Hydroxyurea—brain cancer	0.00189	0.00272	CcSEcCtD
Atropine—Mental disorder—Carmustine—brain cancer	0.00188	0.00271	CcSEcCtD
Atropine—Erythema—Carmustine—brain cancer	0.00187	0.00269	CcSEcCtD
Atropine—Acute coronary syndrome—Etoposide—brain cancer	0.00182	0.00263	CcSEcCtD
Atropine—Mental disorder—Temozolomide—brain cancer	0.00182	0.00262	CcSEcCtD
Atropine—Myocardial infarction—Etoposide—brain cancer	0.00181	0.00261	CcSEcCtD
Atropine—Erythema—Temozolomide—brain cancer	0.00181	0.0026	CcSEcCtD
Atropine—Hypersensitivity—Procarbazine—brain cancer	0.0018	0.00259	CcSEcCtD
Atropine—Dysgeusia—Temozolomide—brain cancer	0.00177	0.00255	CcSEcCtD
Atropine—Vision blurred—Carmustine—brain cancer	0.00176	0.00254	CcSEcCtD
Atropine—Asthenia—Procarbazine—brain cancer	0.00175	0.00252	CcSEcCtD
Atropine—Pruritus—Procarbazine—brain cancer	0.00173	0.00249	CcSEcCtD
Atropine—Agitation—Carmustine—brain cancer	0.00172	0.00248	CcSEcCtD
Atropine—Vision blurred—Temozolomide—brain cancer	0.0017	0.00245	CcSEcCtD
Atropine—Dyspnoea—Hydroxyurea—brain cancer	0.00168	0.00242	CcSEcCtD
Atropine—Somnolence—Hydroxyurea—brain cancer	0.00168	0.00242	CcSEcCtD
Atropine—Diarrhoea—Procarbazine—brain cancer	0.00167	0.0024	CcSEcCtD
Atropine—Dyspepsia—Hydroxyurea—brain cancer	0.00166	0.00239	CcSEcCtD
Atropine—Agitation—Temozolomide—brain cancer	0.00166	0.00239	CcSEcCtD
Atropine—Angioedema—Temozolomide—brain cancer	0.00165	0.00238	CcSEcCtD
Atropine—Fatigue—Hydroxyurea—brain cancer	0.00163	0.00235	CcSEcCtD
Atropine—Vertigo—Temozolomide—brain cancer	0.00162	0.00234	CcSEcCtD
Atropine—Convulsion—Carmustine—brain cancer	0.00162	0.00233	CcSEcCtD
Atropine—Pain—Hydroxyurea—brain cancer	0.00161	0.00233	CcSEcCtD
Atropine—Constipation—Hydroxyurea—brain cancer	0.00161	0.00233	CcSEcCtD
Atropine—Dizziness—Procarbazine—brain cancer	0.00161	0.00232	CcSEcCtD
Atropine—Palpitations—Temozolomide—brain cancer	0.0016	0.0023	CcSEcCtD
Atropine—Chest pain—Carmustine—brain cancer	0.00159	0.00229	CcSEcCtD
Atropine—Anxiety—Carmustine—brain cancer	0.00159	0.00229	CcSEcCtD
Atropine—Convulsion—Temozolomide—brain cancer	0.00157	0.00226	CcSEcCtD
Atropine—Feeling abnormal—Hydroxyurea—brain cancer	0.00156	0.00224	CcSEcCtD
Atropine—Vomiting—Procarbazine—brain cancer	0.00155	0.00223	CcSEcCtD
Atropine—Flushing—Etoposide—brain cancer	0.00154	0.00222	CcSEcCtD
Atropine—Confusional state—Carmustine—brain cancer	0.00154	0.00222	CcSEcCtD
Atropine—Rash—Procarbazine—brain cancer	0.00154	0.00222	CcSEcCtD
Atropine—Dermatitis—Procarbazine—brain cancer	0.00154	0.00221	CcSEcCtD
Atropine—Anxiety—Temozolomide—brain cancer	0.00153	0.00221	CcSEcCtD
Atropine—Headache—Procarbazine—brain cancer	0.00153	0.0022	CcSEcCtD
Atropine—Oedema—Carmustine—brain cancer	0.00153	0.0022	CcSEcCtD
Atropine—Dry mouth—Temozolomide—brain cancer	0.0015	0.00217	CcSEcCtD
Atropine—Body temperature increased—Hydroxyurea—brain cancer	0.00149	0.00215	CcSEcCtD
Atropine—Tachycardia—Carmustine—brain cancer	0.00149	0.00215	CcSEcCtD
Atropine—Confusional state—Temozolomide—brain cancer	0.00149	0.00214	CcSEcCtD
Atropine—Oedema—Temozolomide—brain cancer	0.00148	0.00212	CcSEcCtD
Atropine—Anaphylactic shock—Temozolomide—brain cancer	0.00148	0.00212	CcSEcCtD
Atropine—Nausea—Procarbazine—brain cancer	0.00145	0.00209	CcSEcCtD
Atropine—Hypotension—Carmustine—brain cancer	0.00143	0.00205	CcSEcCtD
Atropine—Hyperhidrosis—Temozolomide—brain cancer	0.00143	0.00205	CcSEcCtD
Atropine—Dysgeusia—Etoposide—brain cancer	0.00142	0.00204	CcSEcCtD
Atropine—Hypersensitivity—Hydroxyurea—brain cancer	0.00139	0.002	CcSEcCtD
Atropine—Insomnia—Carmustine—brain cancer	0.00138	0.00199	CcSEcCtD
Atropine—Dyspnoea—Carmustine—brain cancer	0.00136	0.00196	CcSEcCtD
Atropine—Somnolence—Carmustine—brain cancer	0.00136	0.00195	CcSEcCtD
Atropine—Asthenia—Hydroxyurea—brain cancer	0.00135	0.00195	CcSEcCtD
Atropine—Insomnia—Temozolomide—brain cancer	0.00133	0.00192	CcSEcCtD
Atropine—Dyspnoea—Temozolomide—brain cancer	0.00132	0.00189	CcSEcCtD
Atropine—Somnolence—Temozolomide—brain cancer	0.00131	0.00189	CcSEcCtD
Atropine—Pain—Carmustine—brain cancer	0.00131	0.00188	CcSEcCtD
Atropine—Constipation—Carmustine—brain cancer	0.00131	0.00188	CcSEcCtD
Atropine—Vertigo—Etoposide—brain cancer	0.0013	0.00187	CcSEcCtD
Atropine—Dyspepsia—Temozolomide—brain cancer	0.0013	0.00187	CcSEcCtD
Atropine—Diarrhoea—Hydroxyurea—brain cancer	0.00129	0.00186	CcSEcCtD
Atropine—Fatigue—Temozolomide—brain cancer	0.00127	0.00183	CcSEcCtD
Atropine—Loss of consciousness—Etoposide—brain cancer	0.00127	0.00183	CcSEcCtD
Atropine—Pain—Temozolomide—brain cancer	0.00126	0.00182	CcSEcCtD
Atropine—Constipation—Temozolomide—brain cancer	0.00126	0.00182	CcSEcCtD
Atropine—Feeling abnormal—Carmustine—brain cancer	0.00126	0.00181	CcSEcCtD
Atropine—Convulsion—Etoposide—brain cancer	0.00125	0.00181	CcSEcCtD
Atropine—Dizziness—Hydroxyurea—brain cancer	0.00125	0.0018	CcSEcCtD
Atropine—Gastrointestinal pain—Carmustine—brain cancer	0.00125	0.0018	CcSEcCtD
Atropine—Chest pain—Etoposide—brain cancer	0.00123	0.00177	CcSEcCtD
Atropine—Feeling abnormal—Temozolomide—brain cancer	0.00122	0.00175	CcSEcCtD
Atropine—Abdominal pain—Carmustine—brain cancer	0.00121	0.00174	CcSEcCtD
Atropine—Body temperature increased—Carmustine—brain cancer	0.00121	0.00174	CcSEcCtD
Atropine—Gastrointestinal pain—Temozolomide—brain cancer	0.00121	0.00174	CcSEcCtD
Atropine—Vomiting—Hydroxyurea—brain cancer	0.0012	0.00173	CcSEcCtD
Atropine—Rash—Hydroxyurea—brain cancer	0.00119	0.00171	CcSEcCtD
Atropine—Confusional state—Etoposide—brain cancer	0.00119	0.00171	CcSEcCtD
Atropine—Dermatitis—Hydroxyurea—brain cancer	0.00119	0.00171	CcSEcCtD
Atropine—Headache—Hydroxyurea—brain cancer	0.00118	0.0017	CcSEcCtD
Atropine—Anaphylactic shock—Etoposide—brain cancer	0.00118	0.0017	CcSEcCtD
Atropine—Urticaria—Temozolomide—brain cancer	0.00117	0.00169	CcSEcCtD
Atropine—Abdominal pain—Temozolomide—brain cancer	0.00117	0.00168	CcSEcCtD
Atropine—Body temperature increased—Temozolomide—brain cancer	0.00117	0.00168	CcSEcCtD
Atropine—Tachycardia—Etoposide—brain cancer	0.00115	0.00166	CcSEcCtD
Atropine—Hyperhidrosis—Etoposide—brain cancer	0.00114	0.00164	CcSEcCtD
Atropine—Hypersensitivity—Carmustine—brain cancer	0.00112	0.00162	CcSEcCtD
Atropine—Nausea—Hydroxyurea—brain cancer	0.00112	0.00162	CcSEcCtD
Atropine—Hypotension—Etoposide—brain cancer	0.0011	0.00159	CcSEcCtD
Atropine—Asthenia—Carmustine—brain cancer	0.0011	0.00158	CcSEcCtD
Atropine—Hypersensitivity—Temozolomide—brain cancer	0.00109	0.00157	CcSEcCtD
Atropine—Asthenia—Temozolomide—brain cancer	0.00106	0.00152	CcSEcCtD
Atropine—Dyspnoea—Etoposide—brain cancer	0.00105	0.00152	CcSEcCtD
Atropine—Somnolence—Etoposide—brain cancer	0.00105	0.00151	CcSEcCtD
Atropine—Diarrhoea—Carmustine—brain cancer	0.00104	0.0015	CcSEcCtD
Atropine—Pruritus—Temozolomide—brain cancer	0.00104	0.0015	CcSEcCtD
Atropine—Fatigue—Etoposide—brain cancer	0.00102	0.00147	CcSEcCtD
Atropine—Dizziness—Carmustine—brain cancer	0.00101	0.00145	CcSEcCtD
Atropine—Pain—Etoposide—brain cancer	0.00101	0.00145	CcSEcCtD
Atropine—Constipation—Etoposide—brain cancer	0.00101	0.00145	CcSEcCtD
Atropine—Diarrhoea—Temozolomide—brain cancer	0.00101	0.00145	CcSEcCtD
Atropine—Dizziness—Temozolomide—brain cancer	0.000975	0.00141	CcSEcCtD
Atropine—Feeling abnormal—Etoposide—brain cancer	0.000973	0.0014	CcSEcCtD
Atropine—Vomiting—Carmustine—brain cancer	0.00097	0.0014	CcSEcCtD
Atropine—Gastrointestinal pain—Etoposide—brain cancer	0.000965	0.00139	CcSEcCtD
Atropine—Rash—Carmustine—brain cancer	0.000962	0.00139	CcSEcCtD
Atropine—Dermatitis—Carmustine—brain cancer	0.000962	0.00139	CcSEcCtD
Atropine—Headache—Carmustine—brain cancer	0.000956	0.00138	CcSEcCtD
Atropine—Vomiting—Temozolomide—brain cancer	0.000938	0.00135	CcSEcCtD
Atropine—Urticaria—Etoposide—brain cancer	0.000938	0.00135	CcSEcCtD
Atropine—Abdominal pain—Etoposide—brain cancer	0.000933	0.00134	CcSEcCtD
Atropine—Body temperature increased—Etoposide—brain cancer	0.000933	0.00134	CcSEcCtD
Atropine—Rash—Temozolomide—brain cancer	0.00093	0.00134	CcSEcCtD
Atropine—Dermatitis—Temozolomide—brain cancer	0.000929	0.00134	CcSEcCtD
Atropine—Headache—Temozolomide—brain cancer	0.000924	0.00133	CcSEcCtD
Atropine—Nausea—Carmustine—brain cancer	0.000907	0.00131	CcSEcCtD
Atropine—Nausea—Temozolomide—brain cancer	0.000876	0.00126	CcSEcCtD
Atropine—Hypersensitivity—Etoposide—brain cancer	0.00087	0.00125	CcSEcCtD
Atropine—Asthenia—Etoposide—brain cancer	0.000847	0.00122	CcSEcCtD
Atropine—Pruritus—Etoposide—brain cancer	0.000835	0.0012	CcSEcCtD
Atropine—Diarrhoea—Etoposide—brain cancer	0.000808	0.00116	CcSEcCtD
Atropine—Dizziness—Etoposide—brain cancer	0.000781	0.00112	CcSEcCtD
Atropine—Vomiting—Etoposide—brain cancer	0.00075	0.00108	CcSEcCtD
Atropine—Rash—Etoposide—brain cancer	0.000744	0.00107	CcSEcCtD
Atropine—Dermatitis—Etoposide—brain cancer	0.000744	0.00107	CcSEcCtD
Atropine—Headache—Etoposide—brain cancer	0.000739	0.00107	CcSEcCtD
Atropine—Nausea—Etoposide—brain cancer	0.000701	0.00101	CcSEcCtD
Atropine—CHRM5—Signaling Pathways—PTCH2—brain cancer	4.69e-05	0.00224	CbGpPWpGaD
Atropine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—brain cancer	4.68e-05	0.00224	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—STRADA—brain cancer	4.61e-05	0.0022	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HES5—brain cancer	4.54e-05	0.00217	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—TRPC6—brain cancer	4.54e-05	0.00217	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—STRADA—brain cancer	4.41e-05	0.00211	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—ABR—brain cancer	4.39e-05	0.0021	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—ABR—brain cancer	4.37e-05	0.00209	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—DTX2—brain cancer	4.36e-05	0.00209	CbGpPWpGaD
Atropine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.36e-05	0.00208	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—DTX2—brain cancer	4.34e-05	0.00208	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—TRPC6—brain cancer	4.34e-05	0.00208	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—ABR—brain cancer	4.33e-05	0.00207	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—DTX2—brain cancer	4.3e-05	0.00206	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—SHH—brain cancer	4.27e-05	0.00204	CbGpPWpGaD
Atropine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.26e-05	0.00204	CbGpPWpGaD
Atropine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.26e-05	0.00204	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—TRPC6—brain cancer	4.12e-05	0.00197	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—SHH—brain cancer	4.09e-05	0.00196	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—PTCH1—brain cancer	4.05e-05	0.00194	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—SMO—brain cancer	4.05e-05	0.00194	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.99e-05	0.00191	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.96e-05	0.00189	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—TRPC6—brain cancer	3.95e-05	0.00189	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—SMO—brain cancer	3.88e-05	0.00186	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PTCH1—brain cancer	3.88e-05	0.00186	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ABR—brain cancer	3.84e-05	0.00184	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—GLI2—brain cancer	3.71e-05	0.00178	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ABR—brain cancer	3.68e-05	0.00176	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—GLI2—brain cancer	3.56e-05	0.0017	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP2C9—brain cancer	3.51e-05	0.00168	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—GLI1—brain cancer	3.49e-05	0.00167	CbGpPWpGaD
Atropine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.49e-05	0.00167	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.48e-05	0.00167	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—VAV1—brain cancer	3.4e-05	0.00163	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—GLI1—brain cancer	3.34e-05	0.0016	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SUFU—brain cancer	3.31e-05	0.00158	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTCH2—brain cancer	3.3e-05	0.00158	CbGpPWpGaD
Atropine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	3.3e-05	0.00158	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTCH2—brain cancer	3.29e-05	0.00158	CbGpPWpGaD
Atropine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	3.29e-05	0.00157	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTCH2—brain cancer	3.26e-05	0.00156	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—VAV1—brain cancer	3.25e-05	0.00156	CbGpPWpGaD
Atropine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	3.25e-05	0.00156	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HES5—brain cancer	3.2e-05	0.00153	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—GFAP—brain cancer	3.19e-05	0.00153	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HES5—brain cancer	3.19e-05	0.00153	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SUFU—brain cancer	3.17e-05	0.00152	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HES5—brain cancer	3.16e-05	0.00151	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STRADA—brain cancer	3.11e-05	0.00149	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STRADA—brain cancer	3.1e-05	0.00148	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—VAV1—brain cancer	3.09e-05	0.00148	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STRADA—brain cancer	3.07e-05	0.00147	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	3.06e-05	0.00146	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—GFAP—brain cancer	3.06e-05	0.00146	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—TRPC6—brain cancer	3.05e-05	0.00146	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HEY1—brain cancer	3.03e-05	0.00145	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	3.02e-05	0.00144	CbGpPWpGaD
Atropine—CHRM3—Metabolism—BSG—brain cancer	2.98e-05	0.00143	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—DLL1—brain cancer	2.97e-05	0.00142	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—VAV1—brain cancer	2.96e-05	0.00141	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.92e-05	0.0014	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HEY1—brain cancer	2.9e-05	0.00139	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—SHH—brain cancer	2.88e-05	0.00138	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—SHH—brain cancer	2.87e-05	0.00137	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—SHH—brain cancer	2.84e-05	0.00136	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—DLL1—brain cancer	2.84e-05	0.00136	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—TRPC6—brain cancer	2.78e-05	0.00133	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—TRPC6—brain cancer	2.77e-05	0.00132	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	2.74e-05	0.00131	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—SMO—brain cancer	2.73e-05	0.00131	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PTCH1—brain cancer	2.73e-05	0.00131	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PTCH1—brain cancer	2.72e-05	0.0013	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—SMO—brain cancer	2.72e-05	0.0013	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—SMO—brain cancer	2.7e-05	0.00129	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	2.7e-05	0.00129	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ABR—brain cancer	2.59e-05	0.00124	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ABR—brain cancer	2.58e-05	0.00124	CbGpPWpGaD
Atropine—CHRM3—Metabolism—IDH1—brain cancer	2.57e-05	0.00123	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ABR—brain cancer	2.56e-05	0.00122	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SHH—brain cancer	2.52e-05	0.00121	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GLI2—brain cancer	2.5e-05	0.0012	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GLI2—brain cancer	2.5e-05	0.00119	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GLI2—brain cancer	2.47e-05	0.00118	CbGpPWpGaD
Atropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.46e-05	0.00118	CbGpPWpGaD
Atropine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.45e-05	0.00117	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TRPC6—brain cancer	2.43e-05	0.00116	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SHH—brain cancer	2.42e-05	0.00116	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SMO—brain cancer	2.39e-05	0.00114	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PTCH1—brain cancer	2.39e-05	0.00114	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GLI1—brain cancer	2.35e-05	0.00113	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GLI1—brain cancer	2.35e-05	0.00112	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TRPC6—brain cancer	2.33e-05	0.00111	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GLI1—brain cancer	2.32e-05	0.00111	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—VAV1—brain cancer	2.29e-05	0.0011	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SMO—brain cancer	2.29e-05	0.0011	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PTCH1—brain cancer	2.29e-05	0.0011	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—VAV1—brain cancer	2.28e-05	0.00109	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	2.26e-05	0.00108	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SUFU—brain cancer	2.23e-05	0.00107	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SUFU—brain cancer	2.22e-05	0.00106	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SUFU—brain cancer	2.2e-05	0.00105	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—TP53—brain cancer	2.18e-05	0.00104	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—PIK3CG—brain cancer	2.16e-05	0.00103	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GFAP—brain cancer	2.15e-05	0.00103	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GFAP—brain cancer	2.15e-05	0.00103	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GFAP—brain cancer	2.13e-05	0.00102	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—VAV1—brain cancer	2.08e-05	0.000996	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—VAV1—brain cancer	2.07e-05	0.000992	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—PIK3CG—brain cancer	2.07e-05	0.000989	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—VAV1—brain cancer	2.05e-05	0.000983	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HEY1—brain cancer	2.04e-05	0.000976	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HEY1—brain cancer	2.03e-05	0.000973	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ENO2—brain cancer	2.03e-05	0.00097	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HEY1—brain cancer	2.01e-05	0.000964	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—DLL1—brain cancer	2e-05	0.000957	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—DLL1—brain cancer	1.99e-05	0.000954	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—DLL1—brain cancer	1.98e-05	0.000945	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—PIK3CG—brain cancer	1.96e-05	0.000938	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NOTCH2—brain cancer	1.91e-05	0.000915	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PIK3CG—brain cancer	1.88e-05	0.000898	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NOTCH2—brain cancer	1.83e-05	0.000876	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VAV1—brain cancer	1.82e-05	0.000872	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.78e-05	0.00085	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VAV1—brain cancer	1.75e-05	0.000835	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SHH—brain cancer	1.7e-05	0.000814	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SHH—brain cancer	1.7e-05	0.000811	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SHH—brain cancer	1.68e-05	0.000804	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TRPC6—brain cancer	1.64e-05	0.000785	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TRPC6—brain cancer	1.64e-05	0.000782	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TRPC6—brain cancer	1.62e-05	0.000775	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SMO—brain cancer	1.61e-05	0.000772	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTCH1—brain cancer	1.61e-05	0.000772	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTCH1—brain cancer	1.61e-05	0.000769	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SMO—brain cancer	1.61e-05	0.000769	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SMO—brain cancer	1.59e-05	0.000762	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTCH1—brain cancer	1.59e-05	0.000762	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HES1—brain cancer	1.57e-05	0.00075	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—IL2—brain cancer	1.52e-05	0.000726	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—BSG—brain cancer	1.51e-05	0.000723	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HES1—brain cancer	1.5e-05	0.000718	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PDGFRA—brain cancer	1.49e-05	0.000714	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.46e-05	0.000696	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—IL2—brain cancer	1.45e-05	0.000696	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	1.45e-05	0.000694	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SPP1—brain cancer	1.45e-05	0.000693	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	1.44e-05	0.000687	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PDGFRA—brain cancer	1.43e-05	0.000684	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SPP1—brain cancer	1.39e-05	0.000664	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL2—brain cancer	1.38e-05	0.00066	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	1.32e-05	0.000632	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL2—brain cancer	1.32e-05	0.000632	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	1.32e-05	0.00063	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IRS2—brain cancer	1.31e-05	0.000627	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.3e-05	0.000624	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—IDH1—brain cancer	1.3e-05	0.000622	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.29e-05	0.000617	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	1.29e-05	0.000615	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.27e-05	0.000609	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IRS2—brain cancer	1.26e-05	0.000601	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VAV1—brain cancer	1.23e-05	0.000588	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VAV1—brain cancer	1.23e-05	0.000586	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VAV1—brain cancer	1.21e-05	0.000581	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—APC—brain cancer	1.16e-05	0.000554	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CG—brain cancer	1.16e-05	0.000554	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—APC—brain cancer	1.11e-05	0.00053	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CG—brain cancer	1.11e-05	0.00053	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.06e-05	0.000506	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HES1—brain cancer	1.06e-05	0.000506	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—EGFR—brain cancer	1.05e-05	0.000505	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HES1—brain cancer	1.05e-05	0.000504	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HES1—brain cancer	1.04e-05	0.000499	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ENO2—brain cancer	1.03e-05	0.000492	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.02e-05	0.00049	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—IL2—brain cancer	1.02e-05	0.000488	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.01e-05	0.000484	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—EGFR—brain cancer	1.01e-05	0.000483	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.01e-05	0.000482	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	1e-05	0.00048	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	9.94e-06	0.000475	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SPP1—brain cancer	9.77e-06	0.000468	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SPP1—brain cancer	9.74e-06	0.000466	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SPP1—brain cancer	9.65e-06	0.000462	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CG—brain cancer	9.31e-06	0.000445	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL2—brain cancer	9.3e-06	0.000445	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL2—brain cancer	9.27e-06	0.000443	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL2—brain cancer	9.18e-06	0.000439	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—RELA—brain cancer	9.05e-06	0.000433	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ERBB2—brain cancer	8.99e-06	0.00043	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IRS2—brain cancer	8.84e-06	0.000423	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IRS2—brain cancer	8.81e-06	0.000421	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IRS2—brain cancer	8.73e-06	0.000417	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—RELA—brain cancer	8.66e-06	0.000414	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ERBB2—brain cancer	8.61e-06	0.000412	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL2—brain cancer	8.15e-06	0.00039	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCND1—brain cancer	7.94e-06	0.00038	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	7.86e-06	0.000376	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	7.81e-06	0.000373	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APC—brain cancer	7.81e-06	0.000373	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL2—brain cancer	7.8e-06	0.000373	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APC—brain cancer	7.78e-06	0.000372	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	7.78e-06	0.000372	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APC—brain cancer	7.71e-06	0.000369	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	7.71e-06	0.000369	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCND1—brain cancer	7.61e-06	0.000364	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	7.53e-06	0.00036	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—EGFR—brain cancer	7.11e-06	0.00034	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—EGFR—brain cancer	7.09e-06	0.000339	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—EGFR—brain cancer	7.02e-06	0.000336	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—brain cancer	6.92e-06	0.000331	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—STAT3—brain cancer	6.86e-06	0.000328	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—brain cancer	6.63e-06	0.000317	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—STAT3—brain cancer	6.57e-06	0.000314	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MYC—brain cancer	6.37e-06	0.000305	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EGFR—brain cancer	6.23e-06	0.000298	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MYC—brain cancer	6.1e-06	0.000292	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—RELA—brain cancer	6.1e-06	0.000292	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—RELA—brain cancer	6.08e-06	0.000291	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ERBB2—brain cancer	6.06e-06	0.00029	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ERBB2—brain cancer	6.04e-06	0.000289	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RELA—brain cancer	6.02e-06	0.000288	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ERBB2—brain cancer	5.98e-06	0.000286	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EGFR—brain cancer	5.97e-06	0.000285	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL2—brain cancer	5.49e-06	0.000263	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL2—brain cancer	5.48e-06	0.000262	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL2—brain cancer	5.42e-06	0.000259	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCND1—brain cancer	5.36e-06	0.000256	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCND1—brain cancer	5.34e-06	0.000255	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	5.3e-06	0.000254	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCND1—brain cancer	5.29e-06	0.000253	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	5.29e-06	0.000253	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	5.23e-06	0.00025	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TP53—brain cancer	5.23e-06	0.00025	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TP53—brain cancer	5.01e-06	0.00024	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.71e-06	0.000225	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—brain cancer	4.67e-06	0.000223	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—brain cancer	4.65e-06	0.000223	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STAT3—brain cancer	4.62e-06	0.000221	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—brain cancer	4.61e-06	0.00022	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STAT3—brain cancer	4.61e-06	0.00022	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STAT3—brain cancer	4.56e-06	0.000218	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MYC—brain cancer	4.3e-06	0.000205	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MYC—brain cancer	4.28e-06	0.000205	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MYC—brain cancer	4.24e-06	0.000203	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGFR—brain cancer	4.2e-06	0.000201	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGFR—brain cancer	4.19e-06	0.0002	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGFR—brain cancer	4.15e-06	0.000198	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TP53—brain cancer	3.53e-06	0.000169	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TP53—brain cancer	3.52e-06	0.000168	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TP53—brain cancer	3.48e-06	0.000167	CbGpPWpGaD
